Proposed issue of securities
Announcement Summary
For personal use only
Entity name
TELIX PHARMACEUTICALS LIMITED
Announcement Type
New announcement
Date of this announcement
24/1/2022
The Proposed issue is:
An offer of securities under a securities purchase plan
A placement or other type of issue
Total number of +securities proposed to be issued for an offer of securities under a securities purchase plan
Maximum Number of | ||
ASX +security code | +Security description | +securities to be issued |
TLX | ORDINARY FULLY PAID | 3,246,753 |
+Record date | ||
21/1/2022 | ||
Offer closing date | ||
11/2/2022 | ||
+Issue date | ||
16/2/2022 |
Total number of +securities proposed to be issued for a placement or other type of issue
Maximum Number of | ||
ASX +security code | +Security description | +securities to be issued |
TLX | ORDINARY FULLY PAID | 22,727,273 |
Proposed +issue date | ||
28/1/2022 |
Refer to next page for full details of the announcement
Proposed issue of securities | 1 / 10 |
Proposed issue of securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of +Entity
TELIX PHARMACEUTICALS LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 | Registered Number Type | Registration Number |
ABN | 85616620369 | |
1.3 | ASX issuer code | |
TLX |
- The announcement is New announcement
- Date of this announcement
24/1/2022
1.6 The Proposed issue is:
An offer of +securities under a +securities purchase plan
A placement or other type of issue
Proposed issue of securities | 2 / 10 |
Proposed issue of securities
Part 4 - Details of proposed offer under securities purchase plan
Part 4A - Conditions
For personal use only
4A.1 Do any external approvals need to be obtained or other conditions satisfied before the offer of +securities under the +securities purchase plan issue can proceed on an unconditional basis?
No
Proposed issue of securities | 3 / 10 |
Proposed issue of securities
Part 4B - Offer details
Class or classes of +securities that will participate in the proposed issue and class or classes of +securities proposed to be issued
only | ASX +security code and description | ||
TLX : ORDINARY FULLY PAID | |||
Will the proposed issue of this | |||
+security include an offer of | |||
attaching +securities? | |||
use | No | ||
D tails of +securities proposed to be issued | |||
ASX +security code and description | |||
TLX : ORDINARY FULLY PAID | |||
Maximum total number of those +securities that could be issued | |||
if all offers under the +securities purchase plan are accepted | |||
personal | 3,246,753 | ||
Will the offer be conditional on applications for a minimum | |||
number of +securities being received or a minimum amount | |||
being raised (i.e. a minimum subscription condition)? | |||
No | |||
Will the offer be conditional on applications for a maximum | |||
number of +securities being received or a maximum amount | |||
being raised (i.e. a maximum subscription condition)? | |||
No | |||
Will individual security holders be required to accept the offer for | |||
a minimum number or value of +securities (i.e. a minimum | |||
acceptance condition)? | |||
Yes | |||
Is the minimum acceptance unit based or dollar based? | |||
Dollar based ($) | |||
For | Please enter the minimum acceptance value | ||
$ 1,000 | |||
Will individual security holders be limited to accepting the offer | |||
for a maximum number or value of +securities (i.e. a maximum | |||
acceptance condition)? | |||
Yes | |||
Is the maximum acceptance unit based or dollar based? | |||
Dollar based ($) | |||
Please enter the maximum acceptance value | |||
$ 30,000 | |||
Proposed issue of securities | 4 / 10 |
Proposed issue of securities
Describe all the applicable parcels available for this offer in number of securities or dollar value
Application Amount and Number of New Shares | |||
$1,000 | = 130 new shares | ||
$2,500 | = 325 new shares | ||
$5,000 | = 650 new shares | ||
only | $10,000 | = 1,299 new shares | |
$15,000 | = 1,949 new shares | ||
$20,000 | = 2,598 new shares | ||
$25,000 | = 3,247 new shares | ||
$30,000 | = 3,897 new shares | ||
Offer price details | |||
Has the offer price been determined? | |||
Yes | |||
use | In what currency will the offer | What is the offer price per | |
be made? | +security? | ||
AUD - Australian Dollar | AUD 7.70000 | ||
Oversubscription & Scale back details | |||
personal | Will a scale back be applied if the offer is over-subscribed? | ||
Yes | |||
Describe the scale back arrangements | |||
TLX may in its discretion undertake a scale-back to the extent and in the manner it sees fit, at its | |||
complete discretion. If a scale-back produces a fractional number of New Shares when applied to a | |||
parcel, the number of New Shares allotted will be rounded up to the nearest whole number of New | |||
Shares. If there is a scale-back, the difference between the application monies received from and the | |||
number of New Shares allocated to multiplied by the Offer Price will be refunded. | |||
Will these +securities rank equally in all respects from their issue date with the existing issued | |||
+securities in that class? | |||
Yes | |||
Part 4C - Timetable |
For
4C.1 Date of announcement of +security purchase plan
24/1/2022
4C.2 +Record date
21/1/2022
4C.3 Date on which offer documents will be made available to investors
31/1/2022
Proposed issue of securities | 5 / 10 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Telix Pharmaceuticals Ltd. published this content on 23 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 January 2022 22:13:06 UTC.